Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Summer Y Y Ha

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chemical Communications (Cambridge, England)|November 14, 2020
Constructing a four-input molecular keypad lock with a multi-stimuli-responsive phthalocyanineSummer Y Y Ha, Dennis K P Ng
Nature Reviews. Clinical Oncology|January 9, 2024
Exploring the next generation of antibody-drug conjugatesKyoji Tsuchikama, Yasuaki Anami, Summer Y Y Ha, et al.
Antibody Therapeutics|July 1, 2026
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeuticsChen-Hsu Yu, Summer Y Y Ha, Zhiqiang An, et al.
Journal of Medicinal Chemistry|July 16, 2020
Multifunctional Molecular Therapeutic Agent for Targeted and Controlled Dual Chemo- and Photodynamic TherapySummer Y Y Ha, Yimin Zhou, Wing-Ping Fong, et al.
European Journal of Medicinal Chemistry|April 29, 2019
An integrin-targeting glutathione-activated zinc(II) phthalocyanine for dual targeted photodynamic therapySummer Y Y Ha, Roy C H Wong, Clarence T T Wong, et al.
Biomaterials Science|November 2, 2021
One-pot peptide cyclisation and surface modification of photosensitiser-loaded red blood cells for targeted photodynamic therapyJacky C H Chu, Chihao Shao, Summer Y Y Ha, et al.
Cell Reports|May 25, 2022
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumorsYasuaki Anami, Yoshihiro Otani, Wei Xiong, et al.
Bioorganic & Medicinal Chemistry|January 22, 2021
Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scopeAiko Yamaguchi, Yasuaki Anami, Summer Y Y Ha, et al.
Molecular Cancer Therapeutics|March 7, 2025
177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid TumorsAiko Yamaguchi, Chisato M Yamazaki, Yasuaki Anami, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 30, 2021
Nanoparticles for Triple Drug Release for Combined Chemo- and Photodynamic TherapyGabriel Martínez-Edo, Evelyn Y Xue, Summer Y Y Ha, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chemical Communications (Cambridge, England)|November 14, 2020
Constructing a four-input molecular keypad lock with a multi-stimuli-responsive phthalocyanineSummer Y Y Ha, Dennis K P Ng
Nature Reviews. Clinical Oncology|January 9, 2024
Exploring the next generation of antibody-drug conjugatesKyoji Tsuchikama, Yasuaki Anami, Summer Y Y Ha, et al.
Antibody Therapeutics|July 1, 2026
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeuticsChen-Hsu Yu, Summer Y Y Ha, Zhiqiang An, et al.
Journal of Medicinal Chemistry|July 16, 2020
Multifunctional Molecular Therapeutic Agent for Targeted and Controlled Dual Chemo- and Photodynamic TherapySummer Y Y Ha, Yimin Zhou, Wing-Ping Fong, et al.
European Journal of Medicinal Chemistry|April 29, 2019
An integrin-targeting glutathione-activated zinc(II) phthalocyanine for dual targeted photodynamic therapySummer Y Y Ha, Roy C H Wong, Clarence T T Wong, et al.
Biomaterials Science|November 2, 2021
One-pot peptide cyclisation and surface modification of photosensitiser-loaded red blood cells for targeted photodynamic therapyJacky C H Chu, Chihao Shao, Summer Y Y Ha, et al.
Cell Reports|May 25, 2022
Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumorsYasuaki Anami, Yoshihiro Otani, Wei Xiong, et al.
Bioorganic & Medicinal Chemistry|January 22, 2021
Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scopeAiko Yamaguchi, Yasuaki Anami, Summer Y Y Ha, et al.
Molecular Cancer Therapeutics|March 7, 2025
177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid TumorsAiko Yamaguchi, Chisato M Yamazaki, Yasuaki Anami, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 30, 2021
Nanoparticles for Triple Drug Release for Combined Chemo- and Photodynamic TherapyGabriel Martínez-Edo, Evelyn Y Xue, Summer Y Y Ha, et al.
Pageof 2